{"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.011","statisticalMethod":"Wilcoxon rank sum test"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.14","value":"15.04"},{"groupId":"OG001","spread":"1.90","value":"21.64"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"description":"Microvessel density was estimated by determining the average number of CD34-stained microvessels in 10 areas of maximal MVD counted at a high-power field (h.p.f. x 500 magnification).","dispersionType":"Standard Error","groups":[{"description":"MGUS (Monoclonal gammopathy of undetermined significance) is a premalignant plasma cell proliferative disorder.","id":"OG000","title":"MGUS (Monoclonal Gammopathy of Undetermined Significance)"},{"description":"Smoldering multiple myeloma (SMM)is a premalignant plasma cell proliferative disorder. Multiple myeloma is a plasma cell neoplasm.","id":"OG001","title":"SMM (Smoldering Multiple Myeloma)/MM (Multiple Myeloma)"}],"paramType":"MEAN","populationDescription":"Serum was not available for three patients in the SMM group.","reportingStatus":"POSTED","timeFrame":"60 days","title":"Comparison of Microvessel Density (MVD) Between MGUS and SMM/MM Groups","type":"SECONDARY","unitOfMeasure":"microvessels/hpf"}